[go: up one dir, main page]

Candidiasis, Oral

"Candidiasis, Oral" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

expand / collapse MeSH information
Infection of the mucous membranes of the mouth by a fungus of the genus CANDIDA. (Dorland, 27th ed)


expand / collapse Publications
This graph shows the total number of publications written about "Candidiasis, Oral" by people in this website by year, and whether "Candidiasis, Oral" was a major or minor topic of these publications.
Below are the most recent publications written about "Candidiasis, Oral" by people in Profiles.
  1. Common Oral Conditions: A Review. JAMA. 2024 03 26; 331(12):1045-1054.
    View in: PubMed
  2. IκBζ is an essential mediator of immunity to oropharyngeal candidiasis. Cell Host Microbe. 2023 10 11; 31(10):1700-1713.e4.
    View in: PubMed
  3. Candida albicans stimulates formation of a multi-receptor complex that mediates epithelial cell invasion during oropharyngeal infection. PLoS Pathog. 2023 08; 19(8):e1011579.
    View in: PubMed
  4. Identification and susceptibility testing of oral candidiasis in advanced cancer patients. BMC Oral Health. 2023 04 18; 23(1):223.
    View in: PubMed
  5. Oral complications in a paediatric graft versus host disease (GVHD) clinic: A retrospective study. Oral Dis. 2024 04; 30(3):1084-1090.
    View in: PubMed
  6. Candida albicans Oropharyngeal Infection Is an Exception to Iron-Based Nutritional Immunity. mBio. 2023 04 25; 14(2):e0009523.
    View in: PubMed
  7. Safety and Efficacy of Bimekizumab in Patients With Active Psoriatic Arthritis: Three-Year Results From a Phase IIb Randomized Controlled Trial and Its Open-Label Extension Study. Arthritis Rheumatol. 2022 12; 74(12):1959-1970.
    View in: PubMed
  8. Systematic Genetic Interaction Analysis Identifies a Transcription Factor Circuit Required for Oropharyngeal Candidiasis. mBio. 2022 02 22; 13(1):e0344721.
    View in: PubMed
  9. The Globular C1q Receptor Is Required for Epidermal Growth Factor Receptor Signaling during Candida albicans Infection. mBio. 2021 12 21; 12(6):e0271621.
    View in: PubMed
  10. Bimekizumab versus Adalimumab in Plaque Psoriasis. N Engl J Med. 2021 07 08; 385(2):130-141.
    View in: PubMed